References
- Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology. 2007; 6: 994–1003
- Cudkowicz ME, McKenna-Vasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997; 2: 210–21
- Eisen A, Mezei M, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler. 2008; 9: 108–19
- Jones CT, Swingler RJ, Simpson SA, Brock DJH. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet. 1995; 32: 290–2
- Andersen PM. Amyotrophic lateral sclerosis genetics with Mendelian inheritance. Amyotrophic Lateral Sclerosis, RH Brown, M Swash, P Pasinelli. Informa Healthcare, Abingdon England 2006; 187–207
- Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJ, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry. 1995; 59: 266–70
- Aggarwal A, Nicholson G. Age dependent penetrance of three different superoxide dismutase 1 (SOD1) mutations. Intern J Neuroscience. 2005; 115: 1119–30
- Orrell RW, Habgood JJ, Malaspina A, Mitchell J, Greenwood J, Lane RJ, et al. Clinical characteristics of SOD1 gene mutations in UK families with ALS. J Neurol Sci. 1999; 16: 56–60
- Gubbay SS, Kathana E, Zilber N, Coopoer G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol. 1985; 232: 295–300
- Andersen PM, Nilsson P, Keranen ML, Forsgren L, Hägglund J, Karlsborg M, et al. Phenotypic heterogeneity in MND patients with Cu/Zn-superoxide dismutase mutations in Scandinavia. Brain. 1997; 120: 1723–37
- Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis. Guidelines for diagnosing and clinical care of patients and relatives. An evidence-based review with good practice points. Eur J Neurol. 2005; 12: 921–38
- Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry. 1999; 67: 214–6
- Gamez J, Corbera-Bellalta M, Mila M, López-Lisbona R, Boluda S, Ferrer I. Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic and neuropathological study. Mov Disord. 2008; 23: 434–8
- Mase G, Ros S, Gemma A, Bonfigli L, Carraro N, Cazzato G, et al. ALS with variable phenotype in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci. 2001; 191: 11–8
- Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, et al. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet. 2006; 38: 411–3